Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering bispecific antibodies

P Holliger1, G Winter

  • 1MRC Centre for Protein Engineering, Cambridge, UK.

Current Opinion in Biotechnology
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019
Same author

Structure determination and crystal chemistry of large repeat mixed-layer hexaferrites.

IUCrJ·2018
Same author

Letter to the Editor.

Radiography (London, England : 1995)·2017
Same author

Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis.

The Veterinary record·2017
Same author

Testing and clinical implications for non-V600 BRAF mutations in metastatic NRAS<sup>mt</sup> melanoma.

The British journal of dermatology·2016
Same author

Clinical Research Abstracts of the British Equine Veterinary Association Congress 2015.

Equine veterinary journal·2015
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Bispecific antibodies, engineered using protein technology and antibody fragments, offer a new way to create small, designer molecules for medicine and research. This advancement moves beyond older methods of combining antibodies in vitro or through hybridoma fusion.

Area of Science:

  • Immunotechnology
  • Protein Engineering
  • Biomedical Research

Background:

  • Bispecific antibodies are valuable tools in medicine and research.
  • Traditional methods for bispecific antibody production include in vitro combination of monoclonal antibodies or hybridoma fusion.
  • These traditional methods have limitations in efficiency and scalability.

Purpose of the Study:

  • To explore the potential of protein engineering for creating novel bispecific antibodies.
  • To introduce the concept of 'designer' bispecific antibodies constructed from antibody fragments.
  • To highlight the advantages of engineered bispecific antibodies over traditional methods.

Main Methods:

  • Utilizing protein engineering techniques.
  • Employing antibody fragments as building blocks.

Related Experiment Videos

  • Constructing small, designer bispecific antibodies.

    • Main Results:

    • Demonstrated the feasibility of creating bispecific antibodies using protein engineering.
    • Developed a method for constructing small, designer bispecific antibodies.
    • Showcased the potential of antibody fragments in bispecific antibody design.

    Conclusions:

    • Protein engineering provides a powerful platform for developing advanced bispecific antibodies.
    • Engineered bispecific antibodies offer a versatile alternative for therapeutic and diagnostic applications.
    • The use of antibody fragments enables the creation of tailored bispecific molecules.